Woodline Partners’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Woodline Partners’s Portfolio IMGO Stock Details IMGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-578,829	Closed	-$20.8M	–	938
2022 Q4	$20.8M	Buy	578,829 +121,693	+27%	+$3.04M	0.28%	99
2022 Q3	$6.88M	Sell	457,136 -214,924	-32%	-$3.49M	0.1%	247
2022 Q2	$9M	Sell	672,060 -159,770	-19%	-$2.54M	0.14%	189
2022 Q1	$16M	Sell	831,830 -16,299	-2%	-$338K	0.26%	120
2021 Q4	$20.1M	Buy	848,129 +428,127	+102%	+$9.92M	0.29%	96
2021 Q3	$8.41M	Buy	+420,002	New	+$9.01M	0.14%	181

Woodline Partners's IMGO Position: Q1 2023 in Review

Woodline Partners sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 578,829 shares — an estimated $20.8M sold.

Woodline Partners first reported a position in IMGO in Q3 2021 and held it in 6 quarters. The position peaked at $20.8M in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

Woodline Partners reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
Woodline Partners sold 578,829 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $20.8M.
Woodline Partners first reported a position in Imago BioSciences, Inc. Common stock in Q3 2021 and held it in 6 quarters.
Woodline Partners's Imago BioSciences, Inc. Common stock position peaked at $20.8M in Q4 2022.
0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on Woodline Partners's 13F filing for Q1 2023, filed 15 May 2023.